Wolverine Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2235 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2086 |
|
|
2024
Q2 | – | Sell |
-1,276
| Closed | -$18.9K | – | 2022 |
|
|
2024
Q1 | $18.9K | Buy |
+1,276
| New | +$18.9K | ﹤0.01% | 1150 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2004 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1957 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1927 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1914 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1909 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2041 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2127 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2384 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2500 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2550 |
|
|
2021
Q2 | – | Sell |
-1,788
| Closed | -$61K | – | 2455 |
|
|
2021
Q1 | $61K | Buy |
+1,788
| New | +$61K | ﹤0.01% | 1694 |
|
|
2020
Q4 | – | Sell |
-1,421
| Closed | -$33K | – | 2040 |
|
|
2020
Q3 | $33K | Buy |
+1,421
| New | +$33K | ﹤0.01% | 1173 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1895 |
|
|
2019
Q1 | – | Sell |
-3,518
| Closed | -$79K | – | 1885 |
|
|
2018
Q4 | $79K | Buy |
3,518
+1,232
| +54% | +$27.7K | ﹤0.01% | 1175 |
|
|
2018
Q3 | $73K | Buy |
2,286
+700
| +44% | +$22.4K | ﹤0.01% | 1382 |
|
|
2018
Q2 | $56K | Hold |
1,586
| – | – | ﹤0.01% | 1303 |
|
|
2018
Q1 | $56K | Sell |
1,586
-1,481
| -48% | -$52.3K | ﹤0.01% | 1303 |
|
|
2017
Q4 | $119K | Buy |
+3,067
| New | +$119K | ﹤0.01% | 1392 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1816 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 1804 |
|
|
2016
Q4 | – | Sell |
-3,490
| Closed | -$125K | – | 1856 |
|
|
2016
Q3 | $125K | Sell |
3,490
-1,417
| -29% | -$50.8K | ﹤0.01% | 927 |
|
|
2016
Q2 | $106K | Buy |
+4,907
| New | +$106K | ﹤0.01% | 763 |
|